HONG KONG – China continues to roll out reforms for the pharmaceutical industry, the latest of which is a set of improvements to clinical trial regulations.
HONG KONG – China continues to roll out reforms for the pharmaceutical industry, the latest of which is a set of improvements to clinical trial regulations.
HONG KONG – In a move to further improve regulations in the pharmaceutical sector, the CFDA recently established the China-Denmark Food and Drug Regulatory Cooperation Centre.
HONG KONG – China is on track to achieve some major milestones in biotechnology by 2020, further accelerating the growth of its drug development sector. Despite numerous challenges, the outlook for China’s pharmaceutical industry remains very positive as the country aggressively implements reforms, according to industry analysts.
HONG KONG – China is on track to achieve some major milestones in biotechnology by 2020, further accelerating the growth of its drug development sector. Despite numerous challenges, the outlook for China's pharmaceutical industry remains very positive as the country aggressively implements reforms, according to industry analysts.
HONG KONG – In a move to further improve regulations in the pharmaceutical sector, the CFDA recently established the China-Denmark Food and Drug Regulatory Cooperation Centre.
HONG KONG – China's leading vaccine maker, Sinovac Biotech Ltd., has postponed its 2016 annual report while it investigates allegations made by U.S. investment management company Geoinvesting LLC that its CEO may have been involved in bribing a CFDA official to speed up drug approvals.
HONG KONG – Aslan Pharmaceuticals Pte Ltd., an oncology-focused biotech company headquartered in Singapore, is set to commence a global pivotal study to treat biliary tract cancer with its lead product, varlitinib (ASLAN-001), after getting clearance from the FDA.
